RETRACTED: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 signalling in prediabetic rats
- DOI
- 10.1111/bph.15741
- Published
- 2021-12-12
- Container
- British Journal of Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bph.15741,
title = {RETRACTED: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 signalling in prediabetic rats},
author = {Thura Tun Oo and Natticha Sumneang and Benjamin Ongnok and Busarin Arunsak and Titikorn Chunchai and Sasiwan Kerdphoo and Nattayaporn Apaijai and Wasana Pratchayasakul and Guang Liang and Nipon Chattipakorn and Siriporn C Chattipakorn},
year = {2021},
journal = {British Journal of Pharmacology},
doi = {10.1111/bph.15741},
url = {https://doi.org/10.1111/bph.15741}
}RIS
TY - JOUR TI - RETRACTED: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 signalling in prediabetic rats AU - Thura Tun Oo AU - Natticha Sumneang AU - Benjamin Ongnok AU - Busarin Arunsak AU - Titikorn Chunchai AU - Sasiwan Kerdphoo AU - Nattayaporn Apaijai AU - Wasana Pratchayasakul AU - Guang Liang AU - Nipon Chattipakorn AU - Siriporn C Chattipakorn PY - 2021 JO - British Journal of Pharmacology DO - 10.1111/bph.15741 UR - https://doi.org/10.1111/bph.15741 ER -
APA
Oo, T. T., Sumneang, N., Ongnok, B., Arunsak, B., Chunchai, T., Kerdphoo, S., Apaijai, N., Pratchayasakul, W., Liang, G., Chattipakorn, N., & Chattipakorn, S. C. (2021). RETRACTED: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 signalling in prediabetic rats. British Journal of Pharmacology. https://doi.org/10.1111/bph.15741
Source records
- crossref · retrieved 2026-09-24T23:05:24.942Z